drugset / Trial / NCT02199899
Safety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of the present study is to obtain information about the safety and tolerability of BIIF 1149 BS, to determine the pharmacologically active dose (range) by performing a citric acid challenge test and to obtain preliminary pharmacokinetic data
Timeline
- Start
- 1999-03
- Primary completion
- 1999-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FIGOPITANT | Small molecule | 0.1 mg | Oral |
| Subject | FIGOPITANT | Small molecule | 25 mg | Oral |
Indications
No indication recorded.